The Chemours Company (CC)
NYSE: CC · Real-Time Price · USD
13.09
-0.07 (-0.53%)
Nov 3, 2026, 4:00 PM EST - Market closed
The Chemours Company Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,842 | 5,808 | 5,782 | 6,078 | 6,831 | 6,345 | |
Revenue Growth | 0.09% | 0.45% | -4.87% | -11.02% | 7.66% | 27.69% |
Cost of Revenue | 4,950 | 4,899 | 4,640 | 4,736 | 5,215 | 4,964 |
Gross Profit | 892 | 909 | 1,142 | 1,342 | 1,616 | 1,381 |
Selling, General & Admin | 575 | 504 | 618 | 1,286 | 705 | 583 |
Research & Development | 104 | 108 | 109 | 108 | 118 | 107 |
Operating Expenses | 679 | 612 | 727 | 1,394 | 823 | 690 |
Operating Income | 213 | 297 | 415 | -52 | 793 | 691 |
Interest Expense | -274 | -269 | -263 | -208 | -163 | -185 |
Earnings From Equity Investments | 36 | 35 | 43 | 45 | 55 | 43 |
Currency Exchange Gain (Loss) | -10 | -11 | -9 | -38 | -15 | 3 |
Other Non Operating Income (Expenses) | 33 | 19 | 11 | 19 | 57 | 36 |
EBT Excluding Unusual Items | -2 | 71 | 197 | -234 | 727 | 588 |
Merger & Restructuring Charges | -45 | -81 | -60 | -193 | -16 | -6 |
Impairment of Goodwill | - | - | -56 | - | - | - |
Gain (Loss) on Sale of Assets | 316 | 8 | 3 | 110 | 23 | 115 |
Legal Settlements | -270 | -270 | - | - | - | - |
Other Unusual Items | -16 | -5 | -1 | -1 | 7 | -21 |
Pretax Income | 133 | -277 | 106 | -318 | 741 | 676 |
Income Tax Expense | 288 | 109 | 37 | -66 | 163 | 68 |
Earnings From Continuing Operations | -155 | -386 | 69 | -252 | 578 | 608 |
Minority Interest in Earnings | 1 | - | - | -1 | - | - |
Net Income | -154 | -386 | 69 | -253 | 578 | 608 |
Net Income to Common | -154 | -386 | 69 | -253 | 578 | 608 |
Net Income Growth | - | - | - | - | -4.93% | 177.63% |
Shares Outstanding (Basic) | 151 | 150 | 149 | 149 | 155 | 165 |
Shares Outstanding (Diluted) | 151 | 150 | 150 | 149 | 158 | 169 |
Shares Change | 0.58% | 0.04% | 0.85% | -5.93% | -6.16% | 1.41% |
EPS (Basic) | -1.02 | -2.57 | 0.46 | -1.70 | 3.72 | 3.69 |
EPS (Diluted) | -1.02 | -2.57 | 0.46 | -1.70 | 3.65 | 3.60 |
EPS Growth | - | - | - | - | 1.39% | 172.73% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 211 | 51 | -993 | 186 | 448 | 537 |
Free Cash Flow Per Share | 1.40 | 0.34 | -6.61 | 1.25 | 2.83 | 3.18 |
Dividend Per Share | 0.087 | 0.512 | 1.000 | 1.000 | 1.000 | 1.000 |
Dividend Growth | -87.04% | -48.75% | 0% | 0% | 0% | 0% |
Gross Margin | 15.27% | 15.65% | 19.75% | 22.08% | 23.66% | 21.77% |
Operating Margin | 3.65% | 5.11% | 7.18% | -0.86% | 11.61% | 10.89% |
Profit Margin | -2.64% | -6.65% | 1.19% | -4.16% | 8.46% | 9.58% |
Free Cash Flow Margin | 3.61% | 0.88% | -17.17% | 3.06% | 6.56% | 8.46% |
EBITDA | 533 | 637 | 707 | 257 | 1,084 | 1,008 |
EBITDA Margin | 9.12% | 10.97% | 12.23% | 4.23% | 15.87% | 15.89% |
D&A For EBITDA | 320 | 340 | 292 | 309 | 291 | 317 |
EBIT | 213 | 297 | 415 | -52 | 793 | 691 |
EBIT Margin | 3.65% | 5.11% | 7.18% | -0.85% | 11.61% | 10.89% |
Effective Tax Rate | 216.54% | - | 34.91% | - | 22.00% | 10.06% |